Risk of extrapyramidal syndromes with haloperidol, risperidone, or olanzapine
OBJECTIVE: To compare the risk of extrapyramidal syndrome (EPS) between risperidone, olanzapine, and haloperidol, taking into account patients' past antipsychotic drug use and past EPS. METHODS: Data were obtained from the PHARMO-database, containing filled prescriptions of 450,000 community-dwelling people in the Netherlands from 1986 through 1999. We defined cohorts of first-time users of haloperidol, risperidone, or olanzapine aged 15 to 54 years. In the first 90 days of treatment, we assessed the occurrence of EPS, defined as first use of any antiparkinsonian agent. We estimated relative r... Mehr ...
Verfasser: | |
---|---|
Dokumenttyp: | Artikel |
Erscheinungsdatum: | 2001 |
Schlagwörter: | Adolescent / Adult / Antiparkinson Agents / Antipsychotic Agents / Basal Ganglia Diseases / Benzodiazepines / Cohort Studies / Drug Interactions / Female / Haloperidol / Humans / Male / Middle Aged / Netherlands / Pirenzepine / Risk Factors / Risperidone |
Sprache: | Englisch |
Permalink: | https://search.fid-benelux.de/Record/base-27609992 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | https://dspace.library.uu.nl/handle/1874/27879 |